Investment
Features
FeesSafety
Academy
More
Pluang+

XRP nears $1.34 amid mixed signals on potential bearish death cross in moving averages

Technical Signals
16 Oct 2026
Tokenpost
View Source
Neutral
XRP nears $1.34 amid mixed signals on potential bearish death cross in moving averages

XRP's price hovered near $1.34 on October 16, with two different moving-average calculations showing varying proximity to a bearish death cross—a technical signal where the 50-day average falls below the 200-day. One method shows the averages nearly crossing, while another keeps the 50-day average comfortably above the 200-day. This indicates uncertainty in the market about XRP's short-term trend, as moving averages reflect past prices and confirm rather than predict moves. Investors are watching closely as the daily candle closes, with previous support levels around $1.45 to $1.50 noted earlier in October.

XRP's recent price action and moving average divergence provide context for cryptocurrency market trends. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 16, 2026 23:21 WIB: among 50 priced major cryptocurrencies tradable on Pluang, 25 rose and 24 fell today. Notable movers include BAT at Rp3.637 with a 1-day change of +4.20% and Pluang order activity of 87% Sell / 13% Buy, ONE at Rp27 with -3.12% change and 36% Sell / 64% Buy activity, and LUNC at Rp0,847 with -2.84% change and 31% Sell / 69% Buy activity. Typical hold times range from 93 to 195 days across these assets.

More News

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

Ascendis Pharma announced that the European Medicines Agency's CHMP has given a positive opinion for TransCon CNP (Navepegritid), a once-weekly treatment for achondroplasia in children aged 2 and above with open growth plates. This recommendation sup...

Market News
Bullish
21 minutes ago
EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...

Market News
Bullish
21 minutes ago
US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

Morgan Stanley reports a 32-gigawatt electricity deficit for US data centers through 2028, a 34% shortfall even after alternative power sources. This power gap threatens AI growth as data centers need constant energy to operate. Tech analyst James Al...

Market News
Neutral
1 hour ago
TAT Technologies remains a Strong Buy despite supply chain challenges and weak cash flow.

TAT Technologies remains a Strong Buy despite supply chain challenges and weak cash flow.

TAT Technologies is rated a Strong Buy due to strong demand for its APU products, expanded agreements with Honeywell, and a growing backlog valued at $615 million. The company reported a 22.8% revenue increase in Q2, but cash flow remains weak becaus...

Analyst Insights
Bullish
4 hours ago
SoundHound AI stock drops 53% in 2026 amid doubts on growth and profitability.

SoundHound AI stock drops 53% in 2026 amid doubts on growth and profitability.

SoundHound AI's stock has fallen 53% in 2026, closing near its 52-week low as investors question its growth and profitability. Despite record Q2 revenue growth of 45% and improved margins, the company remains unprofitable with significant cash outflo...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App